Postes actifs de Patrick Crutcher
| Sociétés | Poste | Début | Fin |
|---|
Historique de carrière de Patrick Crutcher
Anciens postes connus de Patrick Crutcher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01/11/2019 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Directeur Général | 01/07/2017 | 01/09/2018 |
| Président | 01/07/2017 | 01/09/2018 |
Formation de Patrick Crutcher
| University of Illinois | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Patrick Crutcher
- Expérience
